Patent details

EP2797947 Title: DIPEPTIDE COMPRISING A NON-PROTEOGENIC AMINO ACID

Basic Information

Publication number:
EP2797947
PCT Application Number:
EP2012076408
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP128126331
PCT Publication Number:
WO2013098191
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DIPEPTIDE COMPRISING A NON-PROTEOGENIC AMINO ACID
French Title of Invention:
DIPEPTIDE COMPRENANT UN ACIDE AMINÉ NON PROTÉOGÉNIQUE
German Title of Invention:
DIPEPTID MIT NICHT PROTEOGENETISCHER AMINOSÄURE
SPC Number:

Dates

Filing date:
20/12/2012
Grant date:
02/05/2018
EP Publication Date:
05/11/2014
PCT Publication Date:
04/07/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/05/2018
EP B1 Publication Date:
02/05/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/12/2018
Expiration date:
20/12/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/04/2018
 
 

Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:
SEVERINSEN, Rune
Address:
Denmark (DK)

2

Name:
RAUNKJÆR, Michael
Address:
Denmark (DK)

3

Name:
CHRISTENSEN, Caspar
Address:
Denmark (DK)

4

Name:
NORRILD, Jens Christian
Address:
Denmark (DK)

Priority

1

Priority Number:
11195998
Priority Date:
29/12/2011
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
201261593524 P
Priority Date:
01/02/2012
Priority Country:
United States (US)

Classification

IPC classification:
C07K 1/107; C07K 5/06; C07K 14/605;

Publication

European Patent Bulletin

Issue number:
201818
Publication date:
02/05/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/04/2019 Outgoing Correspondence 1